Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate

Product Overview

Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate represents a critical chiral building block within the modern pharmaceutical landscape, specifically designed for complex organic synthesis workflows. As a key stereoisomer, this compound provides the necessary structural foundation for the production of high-value therapeutic agents. Our facility specializes in the precise manufacturing of this intermediate, ensuring that every batch meets stringent enantiomeric purity requirements essential for downstream API production. The chemical stability and reactivity profile of this ester make it an indispensable component for medicinal chemists focusing on lipid-lowering medication synthesis.

We understand that consistency is paramount in pharmaceutical supply chains. Therefore, our production lines are optimized to deliver uniform quality across large-scale orders. The synthesis pathway employs advanced catalytic methods to maximize yield while minimizing impurities, resulting in a product that facilitates smoother subsequent reaction steps. This commitment to excellence positions us as a trusted partner for pharmaceutical companies seeking reliable raw material sources for their manufacturing pipelines.

Technical Specifications

Quality control is integrated at every stage of our manufacturing process. We utilize state-of-the-art analytical instrumentation to verify physical and chemical properties against established standards. The following table outlines the critical parameters that define the quality of our Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate. Each shipment is accompanied by a comprehensive Certificate of Analysis (COA) to ensure full transparency and compliance with your internal quality assurance protocols.

Industrial Applications

The primary application of this specialized intermediate lies in the synthesis of Atorvastatin and its calcium salt forms, which are widely recognized in the management of cardiovascular health. As a chiral precursor, it dictates the stereochemical outcome of the final active pharmaceutical ingredient. Utilizing high-purity intermediates like this reduces the burden on purification steps later in the synthesis route, thereby improving overall process efficiency and cost-effectiveness. Beyond statin production, this compound serves as a valuable building block for research and development in organic chemistry, enabling the exploration of novel therapeutic structures.

Our technical team supports clients with detailed documentation regarding safe handling and integration into existing synthesis protocols. We recognize that each manufacturing environment has unique requirements, and we strive to provide material that aligns perfectly with your process parameters. This flexibility allows for seamless scale-up from laboratory research to commercial production without compromising on quality or yield.

Quality Assurance and Logistics

Packaging and storage are critical to maintaining the integrity of chemical intermediates during transit. We package Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate in secure 25 kg drums, with customization available to meet specific logistical needs. All containers are sealed to prevent moisture ingress and contamination, ensuring the product arrives in optimal condition. Storage recommendations include keeping the material in a cool, ventilated area away from direct sunlight and incompatible substances.

As a global manufacturer, we adhere to strict regulatory compliance standards and maintain a robust supply chain capable of meeting international demand. Our logistics partners ensure timely delivery while maintaining all necessary safety documentation. We invite pharmaceutical manufacturers and procurement specialists to contact us for bulk pricing inquiries, sample requests, or technical consultations. Our goal is to support your production goals with reliable, high-quality chemical solutions that drive innovation and efficiency in your operations.